Literature DB >> 22407763

Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia.

C R Beena Devi1, Tieng Swee Tang, Marilys Corbex.   

Abstract

We determined the incidences of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) subtypes among breast cancer cases in Sarawak, Malaysia and their correlation with various risk factors in the three ethnic groups: Chinese, Malay and native. Subtype status was ascertained for 1,034 cases of female breast cancer (93% of all cases diagnosed since 2003), and the age-standardized incidence rates (ASRs) of each subtype were inferred. Case-case comparisons across subtypes were performed for reproductive risk factors. We found 48% luminal A (ER+/PR+/HER2-), 29% triple-negative (ER-/PR-/HER2-), 12% triple-positive (ER+/PR+/HER2+) and 11% HER2-overexpressing (ER-/PR-/HER2+) subtypes, with ASRs of 10.6, 6.0, 2.8 and 2.8 per 100,000, respectively. The proportions of subtypes and ASRs differed significantly by ethnic groups: HER2-positive cases were more frequent in Malays (29%; 95% CI [23;35]) than Chinese (22%; [19;26] and natives (21%; [16;26]); triple-negative cases were less frequent among Chinese (23%; [20;27]) than Malays (33%; [27;39]) and natives (37%; [31;43]). The results of the case-case comparison were in accordance with those observed in western case series. Some uncommon associations, such as between triple-negative subtype and older age at menopause (OR, 1.59; p < 0.05), were found. The triple-negative and HER2+ subtypes predominate in our region, with significant differences among ethnic groups. Our results support the idea that the risk factors for different subtypes vary markedly. Westernized populations are more likely to have factors that increase the risk for the luminal A type, while risk factors for the triple-negative type are more frequent in local populations.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407763     DOI: 10.1002/ijc.27527

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

Review 1.  Improving outcomes in breast cancer for low and middle income countries.

Authors:  C H Yip; I Buccimazza; M Hartman; S V S Deo; P S Y Cheung
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

2.  Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.

Authors:  Xiaohong R Yang; Beena C R Devi; Hyuna Sung; Jennifer Guida; Eliseos J Mucaki; Yanzi Xiao; Ana Best; Lisa Garland; Yi Xie; Nan Hu; Maria Rodriguez-Herrera; Chaoyu Wang; Kristine Jones; Wen Luo; Belynda Hicks; Tieng Swee Tang; Karobi Moitra; Peter K Rogan; Michael Dean
Journal:  Breast Cancer Res Treat       Date:  2017-06-29       Impact factor: 4.872

3.  Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.

Authors:  S Subramaniam; N Bhoo-Pathy; N A Taib; G H Tan; M H See; S Jamaris; G F Ho; L M Looi; C H Yip
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

4.  Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study.

Authors:  Anushri Chitkara; Ines Mesa-Eguiagaray; Sarah H Wild; Peter S Hall; David A Cameron; Andrew H Sims; Jonine D Figueroa
Journal:  Breast Cancer Res Treat       Date:  2022-09-18       Impact factor: 4.624

5.  Greater absolute risk for all subtypes of breast cancer in the US than Malaysia.

Authors:  Hisani N Horne; C R Beena Devi; Hyuna Sung; Tieng Swee Tang; Philip S Rosenberg; Stephen M Hewitt; Mark E Sherman; William F Anderson; Xiaohong R Yang
Journal:  Breast Cancer Res Treat       Date:  2014-12-24       Impact factor: 4.872

6.  Prediction of lymph node involvement in patients with breast tumors measuring 3-5 cm in a middle-income setting: the role of CancerMath.

Authors:  E N Pijnappel; N Bhoo-Pathy; J Suniza; M H See; G H Tan; C H Yip; M Hartman; N A Taib; H M Verkooijen
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

7.  Association between mammographic density and basal-like and luminal A breast cancer subtypes.

Authors:  Hilda Razzaghi; Melissa A Troester; Gretchen L Gierach; Andrew F Olshan; Bonnie C Yankaskas; Robert C Millikan
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

8.  Changing patterns in the clinical characteristics of korean breast cancer from 1996-2010 using an online nationwide breast cancer database.

Authors:  Beom Seok Ko; Woo Chul Noh; Sung Soo Kang; Byeong Woo Park; Eun Young Kang; Nam Sun Paik; Jung Hyun Yang; Sei Hyun Ahn
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

9.  Divergent breast cancer incidence trends by hormone receptor status in the state of Sarawak, Malaysia.

Authors:  Hyuna Sung; Beena C R Devi; Tieng S Tang; Philip S Rosenberg; William F Anderson; Xiaohong R Yang
Journal:  Int J Cancer       Date:  2019-12-23       Impact factor: 7.316

10.  The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.

Authors:  Qingkun Song; Rong Huang; Jing Li; Jinhu Fan; Shan Zheng; Bin Zhang; Hongjian Yang; Zhonghua Tang; Jianjun He; Xiaoming Xie; Hui Li; Jiayuan Li; Youlin Qiao
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.